A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
出版年份 2014 全文链接
标题
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 25, Issue 4, Pages 824-831
出版商
Oxford University Press (OUP)
发表日期
2014-03-25
DOI
10.1093/annonc/mdu025
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Carboplatin and Gemcitabine Combination in Metastatic Triple-Negative Anthracycline- and Taxane-Pretreated Breast Cancer Patients: A Phase II Study
- (2014) R. Maisano et al. JOURNAL OF CHEMOTHERAPY
- Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
- (2013) Lucia Del Mastro et al. BMC CANCER
- Molecularly targeted therapies for metastatic triple-negative breast cancer
- (2013) Soley Bayraktar et al. BREAST CANCER RESEARCH AND TREATMENT
- Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer
- (2013) Jacques Medioni et al. Drugs in research & development
- Adjuvant treatments for triple-negative breast cancers
- (2012) H. Joensuu et al. ANNALS OF ONCOLOGY
- Neoadjuvant treatments for triple-negative breast cancer (TNBC)
- (2012) G. von Minckwitz et al. ANNALS OF ONCOLOGY
- Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?
- (2011) J. T. Ribeiro et al. ANNALS OF ONCOLOGY
- Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial
- (2011) J. M. Lohr et al. ANNALS OF ONCOLOGY
- Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis
- (2011) U. Fasol et al. ANNALS OF ONCOLOGY
- Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
- (2011) Aoife J. Lowery et al. BREAST CANCER RESEARCH AND TREATMENT
- Cisplatin–gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients
- (2010) Nebu Koshy et al. BREAST
- Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
- (2010) Christopher Lobo et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
- (2010) Edith A. Perez et al. BREAST CANCER RESEARCH AND TREATMENT
- The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype
- (2010) Kenjiro Aogi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
- (2010) Amr S. Abu Lila et al. PHARMACEUTICAL RESEARCH
- Vascular targeting by EndoTAG™-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer
- (2009) Martin E. Eichhorn et al. INTERNATIONAL JOURNAL OF CANCER
- Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
- (2009) Philippe L. Bedard et al. Nature Reviews Clinical Oncology
- Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer
- (2008) Martine J. Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started